Sars-CoV2
Conditions
Brief summary
The objective of study is to estimate the sensitivity and specificity of the COR-DIAL based on nasopharyngeal samples taken at the patient's admission in relation to the final diagnosis of COVID-19 made by the medical team.
Interventions
Nasopharyngeal swabs for COVID-19 RT-PCR
Portable and Connected Biosensor viral
Sponsors
Study design
Eligibility
Inclusion criteria
* Male or female or child without age limit * Admitted to a Reference Health Establishment in an emergency unit, hospitalisation or intensive care unit for suspicion of SARS-CoV-2 infection, regardless of the clinical presentation and degree of severity. * Patient to be diagnosed using a PCR test on nasopharyngeal swab. * Social insured
Exclusion criteria
* Atypical or suspicious cases without a final diagnosis of COVID-19 positive or negative * Patient refusal to participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity and specificity of the COR-DIAL based on nasopharyngeal swabs taken on admission of the patient compared to the final diagnosis of COVID-19 made by the medical team | Baseline (at admission) |
Secondary
| Measure | Time frame |
|---|---|
| Cohen's Kappa Coefficient for concordance for the diagnosis of CoV-2-SARS between PCR and COR-DIAL based on nasopharyngeal swabs taken on patient admission | Baseline (at admission) |
Countries
France